EUR 1.0
(0.0%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 160.41 Million EUR | -1.46% |
2022 | 162.8 Million EUR | -0.53% |
2021 | 163.66 Million EUR | 0.36% |
2020 | 163.07 Million EUR | -4.74% |
2019 | 171.18 Million EUR | 5.3% |
2018 | 162.56 Million EUR | 70.73% |
2017 | 95.21 Million EUR | -34.12% |
2016 | 144.53 Million EUR | -0.37% |
2015 | 145.06 Million EUR | 5.5% |
2014 | 137.5 Million EUR | 16.23% |
2013 | 118.3 Million EUR | 18.33% |
2012 | 99.98 Million EUR | 2.46% |
2011 | 97.57 Million EUR | -2.57% |
2010 | 100.15 Million EUR | -33.75% |
2009 | 151.17 Million EUR | 9.54% |
2008 | 138 Million EUR | 6.54% |
2007 | 129.54 Million EUR | -2.76% |
2006 | 133.22 Million EUR | -25.26% |
2005 | 178.25 Million EUR | -99.91% |
2004 | 194.36 Billion EUR | 85570.64% |
2003 | 226.87 Million EUR | 17.2% |
2002 | 193.57 Million EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 140.43 Million EUR | -12.46% |
2024 Q2 | 201.99 Million EUR | 54.85% |
2023 Q3 | 152.44 Million EUR | -7.67% |
2023 Q4 | 160.41 Million EUR | 5.23% |
2023 Q2 | 165.11 Million EUR | 4.82% |
2023 FY | 160.41 Million EUR | -1.46% |
2023 Q1 | 157.51 Million EUR | -3.24% |
2022 Q2 | 168.32 Million EUR | 2.45% |
2022 Q1 | 164.3 Million EUR | 0.39% |
2022 Q4 | 162.8 Million EUR | -4.64% |
2022 FY | 162.8 Million EUR | -0.53% |
2022 Q3 | 170.72 Million EUR | 1.43% |
2021 Q4 | 163.66 Million EUR | 1.44% |
2021 Q3 | 161.33 Million EUR | -4.05% |
2021 FY | 163.66 Million EUR | 0.36% |
2021 Q1 | 160.17 Million EUR | -1.78% |
2021 Q2 | 168.14 Million EUR | 4.98% |
2020 Q3 | 167.21 Million EUR | 0.14% |
2020 Q4 | 163.07 Million EUR | -2.47% |
2020 Q1 | 160.44 Million EUR | -6.28% |
2020 FY | 163.07 Million EUR | -4.74% |
2020 Q2 | 166.98 Million EUR | 4.08% |
2019 Q4 | 171.18 Million EUR | -0.44% |
2019 FY | 171.18 Million EUR | 5.3% |
2019 Q3 | 171.95 Million EUR | -0.5% |
2019 Q2 | 172.82 Million EUR | 1.58% |
2019 Q1 | 170.13 Million EUR | 4.65% |
2018 Q3 | 147.61 Million EUR | 39.66% |
2018 Q4 | 162.56 Million EUR | 10.13% |
2018 Q1 | 97.76 Million EUR | 2.67% |
2018 Q2 | 105.68 Million EUR | 8.11% |
2018 FY | 162.56 Million EUR | 70.73% |
2017 Q4 | 95.21 Million EUR | -32.37% |
2017 Q1 | 145.46 Million EUR | 0.65% |
2017 FY | 95.21 Million EUR | -34.12% |
2017 Q3 | 140.8 Million EUR | -2.49% |
2017 Q2 | 144.39 Million EUR | -0.74% |
2016 Q1 | 145.87 Million EUR | 0.56% |
2016 FY | 144.53 Million EUR | -0.37% |
2016 Q4 | 144.53 Million EUR | -1.82% |
2016 Q3 | 147.21 Million EUR | -0.29% |
2016 Q2 | 147.64 Million EUR | 1.21% |
2015 Q3 | 147.97 Million EUR | 1.29% |
2015 Q4 | 145.06 Million EUR | -1.96% |
2015 FY | 145.06 Million EUR | 5.5% |
2015 Q1 | 141.28 Million EUR | 2.74% |
2015 Q2 | 146.08 Million EUR | 3.4% |
2014 Q1 | 128.87 Million EUR | 8.93% |
2014 Q3 | 134.7 Million EUR | 0.4% |
2014 Q4 | 137.5 Million EUR | 2.08% |
2014 FY | 137.5 Million EUR | 16.23% |
2014 Q2 | 134.16 Million EUR | 4.11% |
2013 Q3 | 111.88 Million EUR | 1.81% |
2013 Q2 | 109.9 Million EUR | 6.75% |
2013 Q1 | 102.94 Million EUR | 2.97% |
2013 FY | 118.3 Million EUR | 18.33% |
2013 Q4 | 118.3 Million EUR | 5.74% |
2012 Q2 | 98.59 Million EUR | 0.16% |
2012 Q4 | 99.98 Million EUR | 0.8% |
2012 FY | 99.98 Million EUR | 2.46% |
2012 Q1 | 98.43 Million EUR | 0.88% |
2012 Q3 | 99.19 Million EUR | 0.6% |
2011 Q1 | 98.45 Million EUR | -1.69% |
2011 FY | 97.57 Million EUR | -2.57% |
2011 Q3 | 98.55 Million EUR | -0.72% |
2011 Q2 | 99.27 Million EUR | 0.83% |
2011 Q4 | 97.57 Million EUR | -1.0% |
2010 Q3 | 100.2 Million EUR | 0.0% |
2010 FY | 100.15 Million EUR | -33.75% |
2010 Q4 | 100.15 Million EUR | -0.05% |
2009 FY | 151.17 Million EUR | 9.54% |
2009 Q4 | 151.17 Million EUR | 0.0% |
2008 FY | 138 Million EUR | 6.54% |
2007 FY | 129.54 Million EUR | -2.76% |
2006 FY | 133.22 Million EUR | -25.26% |
2005 FY | 178.25 Million EUR | -99.91% |
2004 FY | 194.36 Billion EUR | 85570.64% |
2003 FY | 226.87 Million EUR | 17.2% |
2002 FY | 193.57 Million EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Miliboo Société anonyme | 11.92 Million EUR | -1244.773% |
Neolife SA | 3.04 Million EUR | -5168.838% |
U10 Corp | 79.48 Million EUR | -101.834% |
Belysse Group NV | 249.83 Million EUR | 35.791% |
Roche Bobois S.A. | 346.17 Million EUR | 53.66% |
SEB SA | 5.79 Billion EUR | 97.23% |